Antipsychotic exposure prior to acute myocardial infarction in patients with serious mental illness. (Q50617989)

16 March 2018

title

Antipsychotic exposure prior to acute myocardial infarction in patients with serious mental illness. (English)

1 reference

16 March 2018

acute myocardial infarction

main subject

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

8

1 reference

16 March 2018

Robert Stewart

10

1 reference

16 March 2018

author name string

S-I Wu

1

1 reference

16 March 2018

K-L Kao

2

1 reference

16 March 2018

S-C Chen

3

1 reference

16 March 2018

J J M Juang

4

1 reference

16 March 2018

C-J Lin

5

1 reference

16 March 2018

C-K Fang

6

1 reference

16 March 2018

C-S Wu

7

1 reference

16 March 2018

M J Prince

9

1 reference

16 March 2018

language of work or name

English

0 references

publication date

14 October 2014

1 reference

16 March 2018

Acta Psychiatrica Scandinavica

published in

1 reference

16 March 2018

volume

131

1 reference

16 March 2018

issue

3

1 reference

16 March 2018

page(s)

213-222

1 reference

16 March 2018

Mortality in individuals who have had psychiatric treatment: population-based study in Nova Scotia.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Avoidable mortality in people with schizophrenia or bipolar disorder in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Diet, smoking and cardiovascular risk in people with schizophrenia: descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Serious mental illness and physical health problems: a discussion paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Obesity among individuals with serious mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Schizophrenia and physical health problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Physical illness and schizophrenia: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

The association between antipsychotic agents and the risk of myocardial infarction: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Systematic review of early cardiometabolic outcomes of the first treated episode of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Antipsychotic drugs and QT prolongation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Age, antipsychotics, and the risk of ischemic stroke in the Veterans Health Administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Exposure to antipsychotics and risk of stroke: self controlled case series study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Antipsychotic use and myocardial infarction in older patients with treated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Fatal myocardial infarction and use of psychotropic drugs in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Diagnostic procedures, revascularization, and inpatient mortality after acute myocardial infarction in patients with schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Histamine2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Demographic, seasonal, and spatial differences in acute myocardial infarction admissions to hospital in Melbourne Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Association of cerebrovascular events with antidepressant use: a case-crossover study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

What's atypical about atypical antipsychotic drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Association of stroke with the receptor-binding profiles of antipsychotics-a case-crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Polypharmacy with antipsychotics, antidepressants, or benzodiazepines and mortality in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Sudden deaths in psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Smoking in chronic schizophrenic inpatients in taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Antipsychotic Therapy and Short-term Serious Events in Older Adults With Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

Antipsychotics and risk of first-time hospitalization for myocardial infarction: a population-based case?control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACPS.12345

21 January 2018

Identifiers

DOI

10.1111/ACPS.12345

1 reference

16 March 2018

PubMed ID

25311084

1 reference

16 March 2018